+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Swine Vaccines Market by Product, Type, Target Disease - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666448
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Swine Vaccines Market grew from USD 1.47 billion in 2023 to USD 1.58 billion in 2024. It is expected to continue growing at a CAGR of 7.54%, reaching USD 2.45 billion by 2030.

The swine vaccines market is crucial in maintaining animal health, ensuring food security, and safeguarding public health by preventing zoonotic diseases. This market primarily includes vaccines designed to protect swine against various viral, bacterial, and parasitic diseases. The necessity of swine vaccines is underscored by their role in reducing economic losses in the pork industry due to disease outbreaks, enhancing animal welfare, and minimizing the need for antibiotics, which is essential for addressing antibiotic resistance. Applications are vast, encompassing commercial pig farms where vaccines are used to prevent diseases like Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, and Foot-and-Mouth Disease. The end-use scope includes integrated swine production systems, veterinary clinics, and research institutions that employ vaccines for both prophylactic and therapeutic purposes.

Key growth factors influencing the market include rising demand for pork globally, heightened awareness about animal health, advancements in vaccine technology such as DNA vaccines, and government initiatives for animal health enhancement. Emerging markets, especially in Asia, present substantial opportunities due to increasing pork consumption and modernization of swine farming practices. However, challenges like high costs of vaccine development, stringent regulatory standards, and vaccine storage and distribution complexities limit market growth. There's also a challenge in achieving universal vaccine coverage among commercially farmed and free-range swine.

For innovation and research, focus areas include developing vaccines with broader disease coverage, improved safety profiles, and longer-lasting immunity. Genomic studies for better understanding swine immunology and disease pathogens also offer potential pathways. Advanced delivery systems like oral vaccines can simplify administration and improve vaccination rates. The swine vaccines market is dynamic with continuous advancements required to meet evolving virus strains and emerging diseases. Engaging in strategic partnerships with biotechnology firms and government bodies can help companies leverage new technologies and address market limitations effectively. Efficiently navigating these opportunities and challenges can lead to sustained business growth in the swine vaccines sector.

Understanding Market Dynamics in the Swine Vaccines Market

The Swine Vaccines Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising consumption of pork meat
    • Growing awareness related to livestock health
  • Market Restraints
    • Limited availability of vaccine
  • Market Opportunities
    • R&D for novel vaccine developments
  • Market Challenges
    • Dearth of veterinary practitioners

Exploring Porter’s Five Forces for the Swine Vaccines Market

Porter’s Five Forces framework further strengthens the insights of the Swine Vaccines Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Swine Vaccines Market

External macro-environmental factors deeply influence the performance of the Swine Vaccines Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Swine Vaccines Market

The Swine Vaccines Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Swine Vaccines Market

The Swine Vaccines Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Swine Vaccines Market

The Swine Vaccines Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Swine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Ceva Santé Animale, China, Jinyu Bio-technology Co., Ltd., Covetrus Inc., Dechra Pharmaceuticals plc, Elanco Animal Health Incorporated, HIPRA, Huvepharma EOOD, IDEXX Laboratories, Inc., Indian Immunologicals Ltd, Merck & Co., Inc., Phibro Animal Health, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Swine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Attenuated Live Vaccines
    • DNA Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Subunit Vaccines
  • Type
    • Actinobacillus Pleuropneumoniae
    • Classical Swine Fever
    • Foot & Mouth Disease
    • M. Hyo
    • PEDV
    • Porcine Circovirus Type 2
    • Porcine Parvovirus
    • PRRS
    • Pseudorabies
    • Swine Influenza
  • Target Disease
    • Arthritis
    • Bordetella Rhinitis
    • Diarrhea
    • Foot & Mouth Disease
    • Porcine Circovirus Associated Disease
    • Porcine Reproductive & Respiratory Syndrome
    • Pseudorabies
    • Swine Influenza
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising consumption of pork meat
5.1.1.2. Growing awareness related to livestock health
5.1.2. Restraints
5.1.2.1. Limited availability of vaccine
5.1.3. Opportunities
5.1.3.1. R&D for novel vaccine developments
5.1.4. Challenges
5.1.4.1. Dearth of veterinary practitioners
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Swine Vaccines Market, by Product
6.1. Introduction
6.2. Attenuated Live Vaccines
6.3. DNA Vaccines
6.4. Inactivated Vaccines
6.5. Recombinant Vaccines
6.6. Subunit Vaccines
7. Swine Vaccines Market, by Type
7.1. Introduction
7.2. Actinobacillus Pleuropneumoniae
7.3. Classical Swine Fever
7.4. Foot & Mouth Disease
7.5. M. Hyo
7.6. PEDV
7.7. Porcine Circovirus Type 2
7.8. Porcine Parvovirus
7.9. PRRS
7.10. Pseudorabies
7.11. Swine Influenza
8. Swine Vaccines Market, by Target Disease
8.1. Introduction
8.2. Arthritis
8.3. Bordetella Rhinitis
8.4. Diarrhea
8.5. Foot & Mouth Disease
8.6. Porcine Circovirus Associated Disease
8.7. Porcine Reproductive & Respiratory Syndrome
8.8. Pseudorabies
8.9. Swine Influenza
9. Americas Swine Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Swine Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Swine Vaccines Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. SWINE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. SWINE VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SWINE VACCINES MARKET DYNAMICS
TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY ACTINOBACILLUS PLEUROPNEUMONIAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY M. HYO, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY PEDV, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY PRRS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY BORDETELLA RHINITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY PSEUDORABIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 43. CANADA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. CANADA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SWINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 60. CHINA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. CHINA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. CHINA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 63. INDIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 69. JAPAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. JAPAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 84. TAIWAN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 87. THAILAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. THAILAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. THAILAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 90. VIETNAM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. VIETNAM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. VIETNAM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. DENMARK SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. DENMARK SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. DENMARK SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 100. EGYPT SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. EGYPT SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. EGYPT SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 103. FINLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. FINLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. FINLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. FRANCE SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. FRANCE SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. GERMANY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 112. ISRAEL SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. ISRAEL SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. ISRAEL SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 115. ITALY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. ITALY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. ITALY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. NETHERLANDS SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 121. NIGERIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. NIGERIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. NIGERIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 124. NORWAY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. NORWAY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. NORWAY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 127. POLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. POLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. POLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 130. QATAR SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. QATAR SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. QATAR SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 139. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH AFRICA SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 142. SPAIN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SPAIN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 145. SWEDEN SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. SWEDEN SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. SWEDEN SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 148. SWITZERLAND SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. SWITZERLAND SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 151. TURKEY SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. TURKEY SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. TURKEY SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM SWINE VACCINES MARKET SIZE, BY TARGET DISEASE, 2018-2030 (USD MILLION)
TABLE 160. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 161. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Swine Vaccines Market, which are profiled in this report, include:
  • Bayer AG
  • Ceva Santé Animale
  • China, Jinyu Bio-technology Co., Ltd.
  • Covetrus Inc.
  • Dechra Pharmaceuticals plc
  • Elanco Animal Health Incorporated
  • HIPRA
  • Huvepharma EOOD
  • IDEXX Laboratories, Inc.
  • Indian Immunologicals Ltd
  • Merck & Co., Inc.
  • Phibro Animal Health
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information